Хайлтын үр дүнгүүд - Joel Pekow

Үр дүнг сайжруулах
  1. 1
    The emerging role of miRNAs in inflammatory bowel disease: a review

    The emerging role of miRNAs in inflammatory bowel disease: a review -н Christopher G. Chapman, Joel Pekow

    Хэвлэсэн 2014
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    MicroRNAs in inflammatory bowel disease

    MicroRNAs in inflammatory bowel disease -н Joel Pekow, John H. Kwon

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis

    Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C‐related cirrhosis -н Joel Pekow, Atul K. Bhan, Hui Zheng, Raymond T. Chung

    Хэвлэсэн 2007
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease

    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease -н Shivi Siva, David T. Rubin, George Gulotta, K. Wroblewski, Joel Pekow

    Хэвлэсэн 2016
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcerative Colitis

    Rescue Therapy with Cyclosporine or Infliximab is not Associated with an Increased Risk for Postoperative Complications in Patients Hospitalized for Severe Steroid-refractory Ulcer... -н Ryan C. Nelson, Chuanhong Liao, Alessandro Fichera, David T. Rubin, Joel Pekow

    Хэвлэсэн 2013
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation

    Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation -н Carl R. Rankin, Zulfiqar A. Lokhandwala, Raymond Huang, Joel Pekow, Charalabos Pothoulakis, David Padua

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease

    Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease -н Dejan Micić, John N. Gaetano, Jonah Rubin, Russell D. Cohen, Atsushi Sakuraba, David T. Rubin, Joel Pekow

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Renin-angiotensin system promotes colonic inflammation by inducing T<sub>H</sub>17 activation via JAK2/STAT pathway

    Renin-angiotensin system promotes colonic inflammation by inducing T<sub>H</sub>17 activation via JAK2/STAT pathway -н Lei He, Jie Du, Yinyin Chen, Chunyan Liu, Min Zhou, Sarbani Adhikari, David T. Rubin, Joel Pekow, Yan Chun Li

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia

    Chitinase 3-Like-1 Expression in Colonic Epithelial Cells as a Potentially Novel Marker for Colitis-Associated Neoplasia -н Chun‐Chuan Chen, Joel Pekow, Victoria Lladó, Manasa Kanneganti, Cindy W. Lau, Atsushi Mizoguchi, Mari Mino‐Kenudson, Marc Bissonnette, Emiko Mizoguchi

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis

    Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis -н Joel Pekow, Jeremy T. Hetzel, Jami A. Rothe, Stephen B. Hanauer, Jerrold R. Turner, John Hart, Amy Noffsinger, Dezheng Huo, David T. Rubin

    Хэвлэсэн 2009
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis

    Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis -н M. Anthony Sofia, Matthew A. Ciorba, Katherine Meckel, Chai K. Lim, Gilles J. Guillemin, Christopher R. Weber, Marc Bissonnette, Joel Pekow

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon

    Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colon -н Joel Pekow, Katherine Meckel, Urszula Dougherty, Fatma Ayaloglu Butun, Reba Mustafi, John K. C. Lim, Charis Crofton, Xindi Chen, Loren Joseph, Marc Bissonnette

    Хэвлэсэн 2014
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases

    Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases -н Anthony Buisson, Joyce Wing Yan Mak, Michael J. Andersen, Donald Lei, Stacy A. Kahn, Joel Pekow, Russel D Cohen, Nada Zmeter, Bruno Pereira, David T. Rubin

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Real-World Experience with Tofacitinib in IBD at a Tertiary Center

    Real-World Experience with Tofacitinib in IBD at a Tertiary Center -н Roni Weisshof, Maya Aharoni Golan, Philip H. Sossenheimer, Katia El Jurdi, Jacob E. Ollech, Joel Pekow, Russel D. Cohen, Atsushi Sakuraba, Sushila Dalal, David T. Rubin

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes

    miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenes -н Joel Pekow, Urszula Dougherty, Reba Mustafi, Hongyan Zhu, Masha Kocherginsky, David T. Rubin, Stephen B. Hanauer, John Hart, Eugene B. Chang, Alessandro Fichera, Loren Joseph, Marc Bissonnette

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators

    EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators -н Hongyan Zhu, Urszula Dougherty, Victoria Robinson, Reba Mustafi, Joel Pekow, Sonia S. Kupfer, Yan-Chun Li, John Hart, Kathleen H. Goss, Alessandro Fichera, Loren Joseph, Marc Bissonnette

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

    Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis -н Jacob E. Ollech, David T. Rubin, Laura Glick, Roni Weisshof, Katia El Jurdi, Amanda Israel, Noa Krugliak Cleveland, Neil Hyman, Atsushi Sakuraba, Joel Pekow, Russell D. Cohen, Sushila Dalal

    Хэвлэсэн 2019
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease

    Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease -н Jacob E. Ollech, Inessa Normatov, Noam Peleg, Jingzhou Wang, Shivani Patel, Victoria Rai, Yangtian Yi, Jorie Singer, Sushila Dalal, Atsushi Sakuraba, Russell D. Cohen, David T. Rubin, Joel Pekow

    Хэвлэсэн 2020
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease

    Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel di... -н Britt Christensen, Dejan Micić, Peter G. Gibson, Andrés Yarur, Emanuelle Bellaguarda, Paul M. Corsello, John N. Gaetano, Jami Kinnucan, Vijaya L. Rao, S. Reddy, Siddharth Singh, Joel Pekow, David T. Rubin

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD

    miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RD -н Joel Pekow, Katherine Meckel, Urszula Dougherty, Yong Huang, Xindi Chen, Anas Almoghrabi, Reba Mustafi, Fatma Ayaloglu-Butun, Zifeng Deng, Haider I. Haider, John Hart, David T. Rubin, John H. Kwon, Marc Bissonnette

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: